Eminase is a pharmaceutical drug that belongs to a specific category of medications known as thrombolytics. It is primarily used to dissolve blood clots within blood vessels and improve blood flow, particularly in individuals who are experiencing heart attacks or unstable angina (chest pain).
Also known by its generic name anistreplase, Eminase works by activating a natural component found in the blood called plasminogen. Plasminogen, when activated, transforms into an enzyme called plasmin, which has the ability to break down the fibrin meshwork that holds blood clots together. By dissolving blood clots, Eminase helps to restore normal blood flow, preventing further damage to the heart muscle.
Eminase is typically administered through a vein (intravenous), usually on an emergency basis in a healthcare setting such as a hospital. The medication is given as a single injection, and healthcare professionals closely monitor the patient's vital signs and condition during and after the administration. Due to its potent clot-dissolving effects, Eminase should only be used in specific situations with caution and under the direct supervision of medical professionals.
It is important to note that Eminase is not suitable for everyone and should not be used in cases where there is a known bleeding disorder, recent major surgery or trauma, active bleeding, or a history of stroke or brain injury. Potential side effects of Eminase include bleeding, especially at injection sites, allergic reactions, and rare complications such as stroke or life-threatening bleeding.
